We understand that learning about the science of whole-body hyperthermia cancer treatment is important for cancer patients and their families. Here are some frequently asked questions that can help you make an informed and confident decision about HEATT®.
Whole-body hyperthermia has been used to treat a variety of solid cancers. Our largest experience to date is with ovarian and lung cancer but also breast, colorectal, pancreatic and sarcoma.
Whole-body hyperthermia has been studied as a possible cancer treatment since the early 1900s. In recent years, modern technology has enabled more accurate temperature control and monitoring of patients during whole-body hyperthermia treatments, which has opened up new possibilities. Our HEATT® process is a unique method of whole body hyperthermia treatment.
By utilizing our safe and precise application of heat to cancerous cells in order to achieve tumor destruction. Likewise, we may see a beneficial response from the body’s own defense mechanisms or increased sensitivity to other therapies.
Once the treatment is complete, you will rest for several hours afterward in a recovery setting. Listen to your body and give it time to recover. Some patients may experience fatigue or other side effects up to a few days after the treatment. You will stay in close contact with your care provider throughout the recovery process.
Our clinical trials have helped to refine the effectiveness of HEATT®. Through additional research and testing, we’ve been able to ensure that this innovative cancer treatment is as safe and effective as possible before offering it to our patients.
Hyperthermia treatments are conducted by a multidisciplinary team of medical professionals, including specialists in medicine, surgery, interventional radiology radiation and anesthesiology. This team works together to ensure that the patient is closely monitored throughout the entire treatment process.
Although side effects from HEATT® are typically minimal, suggested recovery time is about 2 days in a supervised setting. If a patient is experiencing problems associated with advanced cancer symptoms or previous treatments, the time frame or supervision may be increased.
In recent studies, we have evaluated the responses of both singular and repetitive HEATT® treatments in patients. As we continue to evaluate the ideal number of HEATT® treatments, we recommend one treatment to assess the response before potentially returning to conventional cancer treatment or repeating HEATT®.
Whole-body hyperthermia is a treatment option that has shown safety and efficacy in select advanced cancer patients. While it does not cure cancer, our trials show the potential to reduce the severity and spread of many cancers.
Before you begin HEATT®, your healthcare provider will communicate instructions on how to best prepare for the treatment. For example, maintaining activity, avoiding certain foods and drinks, increasing your fluid intake, and taking medications. Follow these instructions, as directed by your provider, in order to ensure the best outcome from the treatment. You may be told to stop certain medications prior to HEATT®.
